| 000 | 01918 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517123148.0 | ||
| 264 | 0 | _c20170502 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/jdv.13995 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWerner, R N | |
| 245 | 0 | 0 |
_aEuropean consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cJan 2017 |
||
| 300 |
_a9-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Viral _xanalysis |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 |
_aHerpes Zoster _xdiagnosis |
| 650 | 0 | 4 |
_aHerpesvirus 3, Human _xgenetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSocieties, Medical |
| 700 | 1 | _aNikkels, A F | |
| 700 | 1 | _aMarinović, B | |
| 700 | 1 | _aSchäfer, M | |
| 700 | 1 | _aCzarnecka-Operacz, M | |
| 700 | 1 | _aAgius, A M | |
| 700 | 1 | _aBata-Csörgő, Z | |
| 700 | 1 | _aBreuer, J | |
| 700 | 1 | _aGirolomoni, G | |
| 700 | 1 | _aGross, G E | |
| 700 | 1 | _aLangan, S | |
| 700 | 1 | _aLapid-Gortzak, R | |
| 700 | 1 | _aLesser, T H | |
| 700 | 1 | _aPleyer, U | |
| 700 | 1 | _aSellner, J | |
| 700 | 1 | _aVerjans, G M | |
| 700 | 1 | _aWutzler, P | |
| 700 | 1 | _aDressler, C | |
| 700 | 1 | _aErdmann, R | |
| 700 | 1 | _aRosumeck, S | |
| 700 | 1 | _aNast, A | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 31 _gno. 1 _gp. 9-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jdv.13995 _zAvailable from publisher's website |
| 999 |
_c26569576 _d26569576 |
||